This document is a presentation from Quest Diagnostics given at the Bear Stearns Healthcare Conference on September 11, 2007. It summarizes Quest Diagnostics' position as an industry leader in diagnostic testing, with a national network of laboratories and patient service centers. It also provides an overview of the company's growth strategy, including its recent AmeriPath acquisition, expansion into near-patient testing, and focus on higher-margin testing services. The presentation concludes with Quest Diagnostics' financial guidance for 2007.
Joseph Dal Molin: Implementing VistA internationally: Myth-busting lessons fr...Nuffield Trust
In this slideshow Joseph Dal Molin, President of the E-cology Corporation and Chairman of WorldVistA, outlines Jordan’s health system and its approach to implementing VistA.
Joseph Dal Molin presented at the Nuffield Trust seminar: Sharing international experience: Is implementing the VA's electronic health record system an option for the NHS? in July 2012.
Stewart Ferguson, PhD
Acting CIO, Alaska Native Tribal Health Consortium and Director, Alaska Federal Health Care Access Network (AFHCAN)
John Kokesh, MD
Medical Director, Department of Otolaryngology, Alaska Native Medical Center
(4/11/10, Illott, 2.15)
Joseph Dal Molin: Implementing VistA internationally: Myth-busting lessons fr...Nuffield Trust
In this slideshow Joseph Dal Molin, President of the E-cology Corporation and Chairman of WorldVistA, outlines Jordan’s health system and its approach to implementing VistA.
Joseph Dal Molin presented at the Nuffield Trust seminar: Sharing international experience: Is implementing the VA's electronic health record system an option for the NHS? in July 2012.
Stewart Ferguson, PhD
Acting CIO, Alaska Native Tribal Health Consortium and Director, Alaska Federal Health Care Access Network (AFHCAN)
John Kokesh, MD
Medical Director, Department of Otolaryngology, Alaska Native Medical Center
(4/11/10, Illott, 2.15)
Updates on the BioSense Program Redesign: 2011 Public Health Preparedness SummitTaha Kass-Hout, MD, MS
Most state and local health departments are involved in on-going traditional disease surveillance and are beginning to access information through health information exchange with clinical partners. Biosurveillance initiatives offer the opportunity to leverage these existing initiatives while providing important data to protect community health. Building on these existing activities and relationships is key to the success of national initiatives such as BioSense Redesign and meaningful use of electronic health records as a component of the evolving nationwide health information network (NHIN). During this session/workshop, the National Association of County and City Health Officials (NACCHO) and the Association of State and Territorial Health Officials (ASTHO) in association with the Centers for Disease Control and Prevention will address discuss the BioSense redesign effort and provide opportunities for extended engagement of local and state health officials. This workshop encourages the participation of public health emergency responders, and local public health personnel involved in bio-surveillance for emergency preparedness and response within their jurisdictions.
Building A Global Brand Through Content MarketingLiveWorld
This presentation will discuss how the Cleveland Clinic has established itself as one of the premier healthcare brands in the world through innovative and creative content marketing. Paul Matsen will describe how Cleveland Clinic creates distinctive and trusted content to build awareness, reputation and to generate volume. The Cleveland Clinic has been a leader in digital, social and mobile healthcare marketing and employees a unique mix of paid, earned and owned media to build its brand.
Qualidade do Cuidado de Saúde e Segurança do Paciente (Healthcare quality and...Proqualis
Aula de Tracey Cooper, Presidente da International Society for Quality in Health Care (ISQua) no II Seminário Internacional sobre Qualidade em Saúde e Segurança do Paciente - evento do Qualisus - que ocorreu dias 13 e 14 de Agosto de 2013, no Ministério da Saúde, em Brasília.
Updates on the BioSense Program Redesign: 2011 Public Health Preparedness SummitTaha Kass-Hout, MD, MS
Most state and local health departments are involved in on-going traditional disease surveillance and are beginning to access information through health information exchange with clinical partners. Biosurveillance initiatives offer the opportunity to leverage these existing initiatives while providing important data to protect community health. Building on these existing activities and relationships is key to the success of national initiatives such as BioSense Redesign and meaningful use of electronic health records as a component of the evolving nationwide health information network (NHIN). During this session/workshop, the National Association of County and City Health Officials (NACCHO) and the Association of State and Territorial Health Officials (ASTHO) in association with the Centers for Disease Control and Prevention will address discuss the BioSense redesign effort and provide opportunities for extended engagement of local and state health officials. This workshop encourages the participation of public health emergency responders, and local public health personnel involved in bio-surveillance for emergency preparedness and response within their jurisdictions.
Building A Global Brand Through Content MarketingLiveWorld
This presentation will discuss how the Cleveland Clinic has established itself as one of the premier healthcare brands in the world through innovative and creative content marketing. Paul Matsen will describe how Cleveland Clinic creates distinctive and trusted content to build awareness, reputation and to generate volume. The Cleveland Clinic has been a leader in digital, social and mobile healthcare marketing and employees a unique mix of paid, earned and owned media to build its brand.
Qualidade do Cuidado de Saúde e Segurança do Paciente (Healthcare quality and...Proqualis
Aula de Tracey Cooper, Presidente da International Society for Quality in Health Care (ISQua) no II Seminário Internacional sobre Qualidade em Saúde e Segurança do Paciente - evento do Qualisus - que ocorreu dias 13 e 14 de Agosto de 2013, no Ministério da Saúde, em Brasília.
Overview presentation of Millennium HealthCare Inc., a company providing physician practices and healthcare facilities of all sizes with practice development & management services utilizing our expertise to identify medical practice opportunities.
Aldo Rolfo, National Clinical Development Manager, Genesis Cancer Care, Austr...GenesisCareUK
A program that seeks to redefine best practice across the drivers of the GenesisCare business (Quality, Access and Efficiency) in order to deliver on their vision of “Innovating Healthcare. Transforming Lives.”
The Science of Launching and Achieving Growth in Oncologyaccenture
We have conducted research to understand how oncology companies are responding to New science, more treatment choices and changing economics. Visit https://accntu.re/2Jn72wq to learn our key takeaways for launching and achieving growth in oncology.
when will pi network coin be available on crypto exchange.DOT TECH
There is no set date for when Pi coins will enter the market.
However, the developers are working hard to get them released as soon as possible.
Once they are available, users will be able to exchange other cryptocurrencies for Pi coins on designated exchanges.
But for now the only way to sell your pi coins is through verified pi vendor.
Here is the what'sapp contact of my personal pi vendor
+12349014282
Lecture slide titled Fraud Risk Mitigation, Webinar Lecture Delivered at the Society for West African Internal Audit Practitioners (SWAIAP) on Wednesday, November 8, 2023.
What price will pi network be listed on exchangesDOT TECH
The rate at which pi will be listed is practically unknown. But due to speculations surrounding it the predicted rate is tends to be from 30$ — 50$.
So if you are interested in selling your pi network coins at a high rate tho. Or you can't wait till the mainnet launch in 2026. You can easily trade your pi coins with a merchant.
A merchant is someone who buys pi coins from miners and resell them to Investors looking forward to hold massive quantities till mainnet launch.
I will leave the what's app number of my personal pi vendor to trade with.
+12349014282
Turin Startup Ecosystem 2024 - Ricerca sulle Startup e il Sistema dell'Innov...Quotidiano Piemontese
Turin Startup Ecosystem 2024
Una ricerca de il Club degli Investitori, in collaborazione con ToTeM Torino Tech Map e con il supporto della ESCP Business School e di Growth Capital
how to sell pi coins effectively (from 50 - 100k pi)DOT TECH
Anywhere in the world, including Africa, America, and Europe, you can sell Pi Network Coins online and receive cash through online payment options.
Pi has not yet been launched on any exchange because we are currently using the confined Mainnet. The planned launch date for Pi is June 28, 2026.
Reselling to investors who want to hold until the mainnet launch in 2026 is currently the sole way to sell.
Consequently, right now. All you need to do is select the right pi network provider.
Who is a pi merchant?
An individual who buys coins from miners on the pi network and resells them to investors hoping to hang onto them until the mainnet is launched is known as a pi merchant.
debuts.
I'll provide you the what'sapp number.
+12349014282
BYD SWOT Analysis and In-Depth Insights 2024.pptxmikemetalprod
Indepth analysis of the BYD 2024
BYD (Build Your Dreams) is a Chinese automaker and battery manufacturer that has snowballed over the past two decades to become a significant player in electric vehicles and global clean energy technology.
This SWOT analysis examines BYD's strengths, weaknesses, opportunities, and threats as it competes in the fast-changing automotive and energy storage industries.
Founded in 1995 and headquartered in Shenzhen, BYD started as a battery company before expanding into automobiles in the early 2000s.
Initially manufacturing gasoline-powered vehicles, BYD focused on plug-in hybrid and fully electric vehicles, leveraging its expertise in battery technology.
Today, BYD is the world’s largest electric vehicle manufacturer, delivering over 1.2 million electric cars globally. The company also produces electric buses, trucks, forklifts, and rail transit.
On the energy side, BYD is a major supplier of rechargeable batteries for cell phones, laptops, electric vehicles, and energy storage systems.
2. Safe Harbor Disclaimer
»
»
The statements in this presentation which are not historical
facts or information are forward-looking statements. These
forward-looking statements involve risks and uncertainties that
could cause the outcome to be materially different. Certain of
these risks and uncertainties are described in the Quest
Diagnostics Incorporated SEC filings, including our latest Form
10-K. Additional risks may arise from unanticipated events.
A copy of this presentation is available on
our website at www.questdiagnostics.com
Patients Growth People
3. Who is Quest Diagnostics?
»
»Leader in Providing Healthcare Insights and Solutions
Comprehensive Diagnostic Testing
Routine ——» Esoteric
• Diagnose
• Monitor
• Predict
• Prevent
Advanced Information Technology Solutions
Improve Care and Efficiency
Facilitate Introduction of New Therapeutics
Clinical Trials Testing
Touching the Lives of Patients >150 Million Times in 2006
Patients Growth People
4. Quest Diagnostics: The Leader
»
» DiagnosticBTesting
US
Market: ~$45
Source: Washington G-2 Reports and company estimates
Quest Diagnostics data is proforma for AmeriPath acquisition
Patients Growth People
5. A Leader Across All Product Lines
»
»
$ in millions
Based on 2006 Actual Results, proforma for AmeriPath acquisition
Patients Growth People
6. Favorable Industry Trends
»
» Essential Healthcare Service
Growing and Aging Population
Innovations in Science & Medicine
Personal Interest in Health
Convergence of Technologies
• Genetic Predisposition
• Diagnostic Testing
• Diagnostic Imaging
• Information Technology
Influences >70% of Healthcare Decisions
Patients Growth People
7. Why Quest Diagnostics?
»
» Unique Value Proposition
Superior Patient Experience
Six Sigma Quality
Unparalleled Access and Distribution
Innovative Science & Medicine
Advanced Information Technology
Sustainable Advantage
Patients Growth People
8. Expanding Usage by Patients
of PSC Appointment Scheduling
»
»
Patients Growth People
9. Unparalleled Access and Distribution
»
» Serving 50% of US Hospitals & Physicians
31 Regional Laboratories
2 Comprehensive Esoteric Laboratories
150 Rapid Response Laboratories
40 Outpatient AP Facilities in 19 States
~2,100 Patient Service Centers
- serving 45 million patients each year
4,000 Vans and 20 Airplanes
- making 95,000 stops each day
45,000 Dedicated Employees
Touching the Lives of Patients >150 Million Times in 2006
Patients Growth People
10. Patient Service Centers
and Laboratory Network
»
»
PSCs
IOPs
RRLs
∃ Main Labs
∃
~2,300 Laboratories and Patient Service Centers Serving Half of US Physicians
Patients Growth People
11. Electronic Connectivity:
Care360 Network
»
»
>115,000 Physician Users and Growing by >1,000 Physicians Each Month
Patients Growth People
12. Approach to Driving
Profitable Growth
»
» Building a Sustainable Competitive Advantage
Provide Differentiated Service at Competitive Prices
Focus on High Growth Segments
Cancer Diagnostics
Cardiovascular Disease
Infectious Disease
Molecular Diagnostics
Introduce Important & Unique Tests & Services
Expand Geographic Scope
Expand Diagnostic Scope – Near Patient Testing
Increasing Loyalty with Patients, Physicians and Payers
Patients Growth People
13. AmeriPath Acquisition
»
» Creates Leader in Cancer Diagnostics
National Scale with Significant Local Presence
• 900 MDs and PhDs
• Over 200 Hospital Contracts in 22 States
• Approximately 40 Outpatient Anatomic Pathology Facilities
in 19 States
Strengthens Leadership in Hospital and Esoteric Testing
Strengthens Relationship with Physicians and Payers
Accelerates Revenue and Earnings Growth
Integration Activities are On Track
Patients Growth People
14. Near Patient Testing
»
» An Opportunity to Improve Patient Care and …
Attractive benefits for hospitals and
physician offices
Enables more timely and effective
decisions
Expanding product menu
Combine with central
lab results to create
complete patient
testing record available to
physicians and plans
…to Reduce Medical Costs
Patients Growth People
15. Improving Revenue Mix to Higher
Margin, Differentiated Services
»
» Quest Diagnostics 2002 Revenue Quest Diagnostics 2006 Pro Forma Revenue
Other Other
3% 7%
Drugs of Abuse Gene-based and Esoteric Drugs of Abuse Gene-based and Esoteric
4% 16% 3% 17%
Anatomic Pathology Anatomic Pathology
10% 17%
Routine Routine
67% 56%
Total Revenue: $4.1 Billion Total Pro Forma Revenue: ~$7.0 Billion
Patients Growth People
16. 2007 Guidance *
»
» A Challenging Environment in 2007
Revenues $6.6 billion to $6.7 billion
Operating Income ~16%
EPS $2.80 – $2.95
Cash from Operations ~$800 million
CapEx $210 - $220 million
Returning to Revenue and Earnings Growth in 2008
*Excludes $0.04 EPS in Q1 charges. Patients Growth People
17. Building on Strength
»
» Industry Leader in a Vital and Growing Industry
−Leadership in All Major Segments
Unique Value Proposition
A Proven Track Record of Integrating Acquisitions
Proven Management Team
Strong Cash Generator
A History of Disciplined Growth
Patients Growth People